Triple-Agonist Research Compound. The new standard for metabolic research efficiency
Targets GLP-1 receptors to regulate appetite signals and delay gastric emptying
Activates GIP pathways to improve glucose metabolism and lipid handling in research subjects
Activates the Glucagon receptor (GCGR) to increase resting energy expenditure and lipolysis
Not all peptides are created equal.
Hudson Research Lab adheres to strict synthesis protocols. Our GLP3-RETA is designed for precise research applications requiring the highest stability.
Format: Lyophilized Powder (Requires Reconstitution).
Sequence: Verified Triple-Agonist Structure.
Third-Party Tested. Every batch is analyzed to ensure purity and concentration.
Due to complex synthesis requirements, batch availability is strictly limited.
LEGAL DISCLAIMER: This product is sold for Laboratory Research Use Only. It is NOT for human consumption, ingestion, or clinical use. This product is not a drug, supplement, or food and has not been approved by the FDA. Hudson Research Lab assumes no liability for the misuse of this product. Must be 21+ to purchase.